Marriage Counselors in Manalapan, NJ Accepting Medicare

6 Marriage Counselors found. Showing 1 - 6

Joy Przywara, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 80 Bridge Plaza Dr, Manalapan, NJ 07726 Phone: 732-648-6423

Mrs. Mary Margaret Sillup, ED.S., LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 81 Bridge Plaza Dr, Manalapan, NJ 07726 Phone: 732-536-8520    Fax: 732-536-9953

Joyce D Gore, ED.S. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 80 Bridge Plaza Dr, Manalapan, NJ 07726 Phone: 732-786-1700    Fax: 732-972-6014

Stacey Einziger, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 Spruce Way, Manalapan, NJ 07726 Phone: 908-770-2448

Mrs. Tiffany M Campbell, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 219 Taylors Mills Rd, Manalapan, NJ 07726 Phone: 908-415-2042

Brittany Ligammari Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 80 Bridge Plaza Dr, Manalapan, NJ 07726 Phone: 732-648-6423

News Archive

Novel approaches to fight infections presented at the Pipeline Corner at ECCMID

The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) announced breaking developments in the global fight against infections – with new mechanisms and approaches presented by smaller companies in a dedicated pipeline session at the annual congress (ECCMID) in Copenhagen.

Best Practices study: Mock review helps effective approach for preparing team for NDA advisory committee meeting

Pharmaceutical companies with good track records of approvals and first approvals are characterized not only by strong science but also strong working relationships with the FDA. Regulatory Affairs is the function that oversees and guides interactions with the FDA it's a job that comes with a plethora of responsibilities related to New Drug Applications (NDA).

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Hyperion Therapeutics today announced that the first patient has been enrolled in its pivotal phase III clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate). The 4-week, multi-center, randomized, double-blind, cross-over study is designed to evaluate the non-inferiority of glycerol phenylbutyrate to BUPHENYL® (sodium phenylbutyrate) Tablets and Powder in adults with urea cycle disorders.

Women with symptoms of serious psychological distress less likely to receive routine cancer screenings

Women with symptoms of serious mental illness are significantly less likely to receive three routine cancer screenings - Pap tests, mammograms and clinical breast exams - than women in the general population, despite being at elevated risk for medical comorbidities and early death, a new study indicates.

Mental health care suffers as recession hurts state's bottom lines

Mental health budgets are suffering as a lingering recession affects state bottom lines in America, Stateline reports. "States have taken the lead role in publicly funded care for the mentally ill, and paid the majority of the expenses. Even through recessions, the states have steadily increased their mental health budgets every year to meet increasing demand.

Read more Medical News

› Verified 1 days ago